Wednesday, 27 February 2013

Yahoo! Finance: Biotechnology Industry News: Titan Pharmaceuticals Announces Date of FDA Advisory Committee Review of Probuphine(R) for the Treatment of Opioid Dependence

Yahoo! Finance: Biotechnology Industry News
The latest news on the Biotechnology industry from Yahoo! Finance
Titan Pharmaceuticals Announces Date of FDA Advisory Committee Review of Probuphine(R) for the Treatment of Opioid Dependence
Feb 27th 2013, 12:00

[Marketwire] - Titan Pharmaceuticals, Inc. today announced that the Psychopharmacologic Drugs Advisory Committee of the U.S. Food and Drug Administration is scheduled to review the Company's New Drug Application for ...

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

No comments:

Post a Comment